Table 2.
Factor | Change in weight from baseline (%) | Standard error | 95% CI | p |
---|---|---|---|---|
Integrase inhibitor | 2.62 | 1.38 | −0.08 to 5.32 | 0.06 |
Year of ART initiation | 0.08 | 1.44 | −2.62 to 2.90 | 1.0 |
Age | 0.07 | 0.05 | −0.02 to 0.168 | 0.13 |
Sex: female | 1.31 | 1.08 | −0.82 to 3.42 | 0.23 |
Race: white | −1.37 | 1.24 | −3.81 to 1.06 | 0.27 |
Ethnicity: Hispanic or Latinx | 0.60 | 1.93 | −3.18 to 4.38 | 0.76 |
NRTI backbone: TDF | 3.09 | 4.05 | −4.85 to 11.0 | 0.45 |
CD4 count | −0.01 | 0.00 | −0.01 to −0.01 | 0.01 |
HIV-1 RNA viral load closest to ART initiation | 0.00 | 0.00 | 0.00 to 0 | 0.06 |
CI, confidence interval; TDF, tenofovir disoproxil fumarate.